ID   DGKD_HUMAN              Reviewed;        1214 AA.
AC   Q16760; Q14158; Q6PK55; Q8NG53;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 4.
DT   10-MAY-2017, entry version 188.
DE   RecName: Full=Diacylglycerol kinase delta;
DE            Short=DAG kinase delta;
DE            EC=2.7.1.107;
DE   AltName: Full=130 kDa diacylglycerol kinase;
DE   AltName: Full=Diglyceride kinase delta;
DE            Short=DGK-delta;
GN   Name=DGKD; Synonyms=KIAA0145;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12200442; DOI=10.1074/jbc.M206895200;
RA   Sakane F., Imai S., Yamada K., Murakami T., Tsushima S., Kanoh H.;
RT   "Alternative splicing of the human diacylglycerol kinase delta gene
RT   generates two isoforms differing in their expression patterns and in
RT   regulatory functions.";
RL   J. Biol. Chem. 277:43519-43526(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 17-1214 (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV.
RT   The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 45-1214 (ISOFORM 1).
RC   TISSUE=Hepatoma, and Testis;
RX   PubMed=8626538; DOI=10.1074/jbc.271.14.8394;
RA   Sakane F., Imai S., Kai M., Wada I., Kanoh H.;
RT   "Molecular cloning of a novel diacylglycerol kinase isozyme with a
RT   pleckstrin homology domain and a C-terminal tail similar to those of
RT   the EPH family of protein-tyrosine kinases.";
RL   J. Biol. Chem. 271:8394-8401(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1068-1214.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION.
RX   PubMed=12084710; DOI=10.1074/jbc.M202035200;
RA   Imai S., Sakane F., Kanoh H.;
RT   "Phorbol ester-regulated oligomerization of diacylglycerol kinase
RT   delta linked to its phosphorylation and translocation.";
RL   J. Biol. Chem. 277:35323-35332(2002).
RN   [7]
RP   FUNCTION, INTERACTION WITH AP2A2, AND MUTAGENESIS OF PHE-369; PHE-372
RP   AND PHE-748.
RX   PubMed=17880279; DOI=10.1042/BJ20070755;
RA   Kawasaki T., Kobayashi T., Ueyama T., Shirai Y., Saito N.;
RT   "Regulation of clathrin-dependent endocytosis by diacylglycerol kinase
RT   delta: importance of kinase activity and binding to AP2alpha.";
RL   Biochem. J. 409:471-479(2008).
RN   [8]
RP   STRUCTURE BY NMR OF 216-286.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the C1 domain of the human diacylglycerol
RT   kinase delta.";
RL   Submitted (APR-2004) to the PDB data bank.
CC   -!- FUNCTION: May function as signaling molecule.
CC       {ECO:0000269|PubMed:17880279}.
CC   -!- FUNCTION: Isoform 2 may be involved in cell growth and
CC       tumorigenesis. Involved in clathrin-dependent endocytosis.
CC       {ECO:0000269|PubMed:17880279}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1,2-diacyl-sn-glycerol = ADP + 1,2-
CC       diacyl-sn-glycerol 3-phosphate.
CC   -!- ENZYME REGULATION: Partially inhibited by phosphatidylserine.
CC   -!- SUBUNIT: The two isoforms are able to form homo- and hetero-
CC       oligomer structures (at least tetramers). Isoform 2 interacts with
CC       AP2A2. {ECO:0000269|PubMed:12200442, ECO:0000269|PubMed:17880279}.
CC   -!- INTERACTION:
CC       O75923:DYSF; NbExp=3; IntAct=EBI-719333, EBI-2799016;
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:12200442}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Membrane
CC       {ECO:0000269|PubMed:12200442}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:12200442}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=Q16760-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q16760-2; Sequence=VSP_012891;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is ubiquitously expressed also in
CC       tumor tissues. Isoform 1 is expressed in ovary, spleen and some
CC       tumor-derived cells. {ECO:0000269|PubMed:12200442}.
CC   -!- PTM: Isoform 1 H domain is phosphorylated.
CC       {ECO:0000269|PubMed:12084710}.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB078966; BAC11809.1; -; mRNA.
DR   EMBL; D63479; BAA09766.3; -; mRNA.
DR   EMBL; D73409; BAA11134.1; -; mRNA.
DR   EMBL; BC006561; AAH06561.1; -; mRNA.
DR   CCDS; CCDS2504.1; -. [Q16760-1]
DR   CCDS; CCDS46546.1; -. [Q16760-2]
DR   RefSeq; NP_003639.2; NM_003648.2. [Q16760-2]
DR   RefSeq; NP_690618.2; NM_152879.2. [Q16760-1]
DR   UniGene; Hs.471675; -.
DR   PDB; 1R79; NMR; -; A=216-286.
DR   PDB; 3BQ7; X-ray; 2.90 A; A/B/C/D/E/F=1141-1208.
DR   PDBsum; 1R79; -.
DR   PDBsum; 3BQ7; -.
DR   ProteinModelPortal; Q16760; -.
DR   SMR; Q16760; -.
DR   BioGrid; 114097; 10.
DR   DIP; DIP-29646N; -.
DR   IntAct; Q16760; 9.
DR   MINT; MINT-87709; -.
DR   STRING; 9606.ENSP00000264057; -.
DR   ChEMBL; CHEMBL1075120; -.
DR   DrugBank; DB00144; Phosphatidyl serine.
DR   SwissLipids; SLP:000000939; -. [Q16760-2]
DR   iPTMnet; Q16760; -.
DR   PhosphoSitePlus; Q16760; -.
DR   BioMuta; DGKD; -.
DR   DMDM; 116241328; -.
DR   MaxQB; Q16760; -.
DR   PaxDb; Q16760; -.
DR   PeptideAtlas; Q16760; -.
DR   PRIDE; Q16760; -.
DR   Ensembl; ENST00000264057; ENSP00000264057; ENSG00000077044. [Q16760-1]
DR   Ensembl; ENST00000409813; ENSP00000386455; ENSG00000077044. [Q16760-2]
DR   Ensembl; ENST00000628356; ENSP00000487220; ENSG00000280873. [Q16760-1]
DR   Ensembl; ENST00000628527; ENSP00000487423; ENSG00000280873. [Q16760-2]
DR   GeneID; 8527; -.
DR   KEGG; hsa:8527; -.
DR   UCSC; uc002vui.2; human. [Q16760-1]
DR   CTD; 8527; -.
DR   DisGeNET; 8527; -.
DR   GeneCards; DGKD; -.
DR   H-InvDB; HIX0002934; -.
DR   HGNC; HGNC:2851; DGKD.
DR   HPA; HPA027530; -.
DR   HPA; HPA049101; -.
DR   MIM; 601826; gene.
DR   neXtProt; NX_Q16760; -.
DR   OpenTargets; ENSG00000077044; -.
DR   PharmGKB; PA27312; -.
DR   eggNOG; KOG1170; Eukaryota.
DR   eggNOG; ENOG410XSJR; LUCA.
DR   GeneTree; ENSGT00760000119050; -.
DR   HOGENOM; HOG000234676; -.
DR   HOVERGEN; HBG051346; -.
DR   InParanoid; Q16760; -.
DR   KO; K00901; -.
DR   OMA; ENLEYYT; -.
DR   OrthoDB; EOG091G00SK; -.
DR   PhylomeDB; Q16760; -.
DR   TreeFam; TF313104; -.
DR   BRENDA; 2.7.1.107; 2681.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   SIGNOR; Q16760; -.
DR   ChiTaRS; DGKD; human.
DR   EvolutionaryTrace; Q16760; -.
DR   GeneWiki; DGKD; -.
DR   GenomeRNAi; 8527; -.
DR   PRO; PR:Q16760; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000077044; -.
DR   CleanEx; HS_DGKD; -.
DR   ExpressionAtlas; Q16760; baseline and differential.
DR   Genevisible; Q16760; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019992; F:diacylglycerol binding; NAS:UniProtKB.
DR   GO; GO:0004143; F:diacylglycerol kinase activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:MGI.
DR   GO; GO:0016049; P:cell growth; NAS:UniProtKB.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; NAS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0046834; P:lipid phosphorylation; TAS:BHF-UCL.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0010033; P:response to organic substance; IDA:UniProtKB.
DR   GO; GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   CDD; cd00029; C1; 2.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF111331; SSF111331; 2.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Endocytosis; Kinase; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Protein transport;
KW   Reference proteome; Repeat; Transferase; Transport; Zinc; Zinc-finger.
FT   CHAIN         1   1214       Diacylglycerol kinase delta.
FT                                /FTId=PRO_0000218462.
FT   DOMAIN       53    146       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      317    451       DAGKc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   DOMAIN     1145   1208       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   ZN_FING     163    213       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     235    286       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   COMPBIAS      8     36       Pro-rich.
FT   VAR_SEQ       1     52       MAAAAGAPPPGPPQPPPPPPPEESSDSEPEAEPGSPQKLIR
FT                                KVSTSGQIRQK -> MNMFLYFQ (in isoform 1).
FT                                {ECO:0000303|PubMed:12200442,
FT                                ECO:0000303|PubMed:8626538}.
FT                                /FTId=VSP_012891.
FT   MUTAGEN     369    369       F->A: Reduces interaction with AP2A2;
FT                                when associated with A-372.
FT                                {ECO:0000269|PubMed:17880279}.
FT   MUTAGEN     372    372       F->A: Reduces interaction with AP2A2;
FT                                when associated with A-369.
FT                                {ECO:0000269|PubMed:17880279}.
FT   MUTAGEN     748    748       F->A: Reduces interaction with AP2A2.
FT                                {ECO:0000269|PubMed:17880279}.
FT   CONFLICT    511    511       V -> P (in Ref. 4; BAA11134).
FT                                {ECO:0000305}.
FT   CONFLICT    828    834       RPIPLPS -> DPSHSPV (in Ref. 4; BAA11134).
FT                                {ECO:0000305}.
FT   CONFLICT    960    960       L -> V (in Ref. 1; BAC11809 and 4;
FT                                BAA11134). {ECO:0000305}.
FT   CONFLICT   1054   1054       Missing (in Ref. 4; BAA11134).
FT                                {ECO:0000305}.
FT   STRAND      238    241       {ECO:0000244|PDB:1R79}.
FT   STRAND      250    252       {ECO:0000244|PDB:1R79}.
FT   TURN        259    261       {ECO:0000244|PDB:1R79}.
FT   STRAND      265    270       {ECO:0000244|PDB:1R79}.
FT   HELIX       276    281       {ECO:0000244|PDB:1R79}.
FT   HELIX      1142   1144       {ECO:0000244|PDB:3BQ7}.
FT   HELIX      1147   1156       {ECO:0000244|PDB:3BQ7}.
FT   HELIX      1160   1162       {ECO:0000244|PDB:3BQ7}.
FT   HELIX      1163   1168       {ECO:0000244|PDB:3BQ7}.
FT   HELIX      1173   1176       {ECO:0000244|PDB:3BQ7}.
FT   HELIX      1181   1186       {ECO:0000244|PDB:3BQ7}.
FT   HELIX      1192   1206       {ECO:0000244|PDB:3BQ7}.
SQ   SEQUENCE   1214 AA;  134525 MW;  ED114429096D2112 CRC64;
     MAAAAGAPPP GPPQPPPPPP PEESSDSEPE AEPGSPQKLI RKVSTSGQIR QKTIIKEGML
     TKQNNSFQRS KRRYFKLRGR TLYYAKTAKS IIFDEVDLTD ASVAESSTKN VNNSFTVITP
     CRKLILCADN RKEMEDWIAA LKTVQNREHF EPTQYSMDHF SGMHNWYACS HARPTYCNVC
     REALSGVTSH GLSCEVCKFK AHKRCAVRAT NNCKWTTLAS IGKDIIEDAD GIAMPHQWLE
     GNLPVSAKCT VCDKTCGSVL RLQDWRCLWC KAMVHTSCKE SLLTKCPLGL CKVSVIPPTA
     LNSIDSDGFW KASCPPSCTS PLLVFVNSKS GDNQGVKFLR RFKQLLNPAQ VFDLMNGGPH
     LGLRLFQKFD TFRILVCGGD GSVGWVLSEI DSLNLHKQCQ LGVLPLGTGN DLARVLGWGS
     ACDDDTQLPQ ILEKLERAST KMLDRWSVMA YEAKLPRQAS SSTVTEDFSE DSEVQQILFY
     EDSVAAHLSK ILTSDQHSVV ISSAKVLCET VKDFVARVGK AYEKTTESSE ESEVMAKKCS
     VLKEKLDSLL KTLDDESQAS SSLPNPPPTI AEEAEDGDGS GSICGSTGDR LVASACPARP
     QIFRPREQLM LRANSLKKAI RQIIEHTEKA VDEQNAQTQE QEGFVLGLSE SEEKMDHRVC
     PPLSHSESFG VPKGRSQRKV SKSPCEKLIS KGSLSLGSSA SLPPQPGSRD GLPALNTKIL
     YPNVRAGMSG SLPGGSVISR LLINADPFNS EPETLEYYTE KCVMNNYFGI GLDAKISLDF
     NNKRDEHPEK CRSRTKNMMW YGVLGTKELL HRTYKNLEQK VLLECDGRPI PLPSLQGIAV
     LNIPSYAGGT NFWGGTKEDD TFAAPSFDDK ILEVVAVFGS MQMAVSRVIR LQHHRIAQCR
     TVKISILGDE GVPVQVDGEA WVQPPGYIRI VHKNRAQTLT RDRAFESTLK SWEDKQKCEL
     PRPPSCSLHP EMLSEEEATQ MDQFGQAAGV LIHSIREIAQ SHRDMEQELA HAVNASSKSM
     DRVYGKPRTT EGLNCSFVLE MVNNFRALRS ETELLLSGKM ALQLDPPQKE QLGSALAEMD
     RQLRRLADTP WLCQSAEPGD EESVMLDLAK RSRSGKFRLV TKFKKEKNNK NKEAHSSLGA
     PVHLWGTEEV AAWLEHLSLC EYKDIFTRHD IRGSELLHLE RRDLKDLGVT KVGHMKRILC
     GIKELSRSAP AVEA
//
